Castration Induces Parkinson Disease Pathologies in Young Male Mice via Inducible Nitric-oxide Synthase

被引:43
|
作者
Khasnavis, Saurabh [1 ]
Ghosh, Anamitra [1 ]
Roy, Avik [1 ]
Pahan, Kalipada [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1074/jbc.M112.443556
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although Parkinson disease (PD) is a progressive neurodegenerative disorder, available animal models do not exhibit irreversible neurodegeneration, and this is a major obstacle in finding out an effective drug against this disease. Here we delineate a new irreversible model to study PD pathogenesis. The model is based on simple castration of young male mice. Levels of inducible nitricoxide synthase (iNOS), glial markers (glial fibrillary acidic protein and CD11b), and alpha-synuclein were higher in nigra of castrated male mice than normal male mice. On the other hand, after castration, the level of glial-derived neurotrophic factor (GDNF) markedly decreased in the nigra of male mice. Accordingly, castration also induced the loss of tyrosine hydroxylase-positive neurons in the nigra and decrease in tyrosine hydroxylase-positive fibers and neurotransmitters in the striatum. Reversal of nigrostriatal pathologies in castrated male mice by subcutaneous implantation of 5 alpha-dihydrotestosterone pellets validates an important role of male sex hormone in castration-induced nigrostriatal pathology. Interestingly, castration was unable to cause glial activation, decrease nigral GDNF, augment the death of nigral dopaminergic neurons, induce the loss of striatal fibers, and impair neurotransmitters in iNOS(-/-) male mice. Furthermore, we demonstrate that iNOS-derived NO is responsible for decreased expression of GDNF in activated astrocytes. Together, our results suggest that castration induces nigrostriatal pathologies via iNOS-mediated decrease in GDNF. These results are important because castrated young male mice may be used as a simple, toxin-free, and nontransgenic animal model to study PD-related nigrostriatal pathologies, paving the way for easy drug screening against PD.
引用
收藏
页码:20843 / 20855
页数:13
相关论文
共 50 条
  • [31] NITRIC-OXIDE SYNTHASE INDUCES MACROPHAGE DEATH BY APOPTOSIS
    SARIH, M
    SOUVANNAVONG, V
    ADAM, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (02) : 503 - 508
  • [32] Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway
    Musial, A
    Eissa, NT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) : 24268 - 24273
  • [33] INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE AMELIORATES CEREBRAL ISCHEMIC
    ZHANG, FY
    XU, S
    IADECOLA, C
    STROKE, 1995, 26 (01) : 180 - 180
  • [34] INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE WITH INHIBITORS OF TETRAHYDROBIOPTERIN BIOSYNTHESIS
    KILBOURN, RG
    GRIFFITH, OW
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (21) : 1672 - 1672
  • [35] EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE IN DERMAL MICROVASCULATURE IN PSORIASIS
    ROWE, A
    FARRELL, A
    KAZMI, SH
    BUNKER, CB
    LANCET, 1994, 344 (8933): : 1371 - 1371
  • [36] INDUCIBLE NITRIC-OXIDE SYNTHASE AND IDIOPATHIC COLITIS IN RHESUS MACAQUES
    RIBBONS, KA
    CLARK, DA
    CURRIE, MG
    MOORE, WM
    MILLER, MJS
    GASTROENTEROLOGY, 1995, 108 (04) : A903 - A903
  • [37] INDUCIBLE MICROGLIAL NITRIC-OXIDE SYNTHASE - A LARGE MEMBRANE POOL
    WOOD, PL
    CHOKSI, S
    BOCCHINI, V
    NEUROREPORT, 1994, 5 (08) : 977 - 980
  • [38] EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE IN ATOPIC-DERMATITIS
    ROWE, A
    FARRELL, AM
    KAZMI, SH
    BUNKER, CB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (04) : 650 - 650
  • [39] SELECTIVE-INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE BY AGMATINE
    AUGUET, M
    VIOSSAT, I
    MARIN, JG
    CHABRIER, PE
    JAPANESE JOURNAL OF PHARMACOLOGY, 1995, 69 (03): : 285 - 287
  • [40] NOVEL POTENT AND SELECTIVE INHIBITORS OF INDUCIBLE NITRIC-OXIDE SYNTHASE
    NAKANE, M
    KLINGHOFER, V
    KUK, JE
    DONNELLY, JL
    BUDZIK, GP
    POLLOCK, JS
    BASHA, F
    CARTER, GW
    MOLECULAR PHARMACOLOGY, 1995, 47 (04) : 831 - 834